Massachusetts Federal Jury Hits Takeda With $474M Verdict In Antitrust Class Action
BOSTON — A federal jury in Massachusetts on May 18 found Takeda Pharmaceuticals USA Inc. liable for $474.89 million in damages in a class action alleging that the pharmaceutical company violated...To view the full article, register now.
Already a subscriber? Click here to view full article